1. Home
  2. NNNN vs ENOV Comparison

NNNN vs ENOV Comparison

Compare NNNN & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$25.50

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Enovis Corporation

ENOV

Enovis Corporation

HOLD

Current Price

$26.64

Market Cap

1.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNNN
ENOV
Founded
2021
1995
Country
Germany
United States
Employees
27
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Fluid Controls
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.4B
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
NNNN
ENOV
Price
$25.50
$26.64
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$47.38
AVG Volume (30 Days)
12.8K
808.1K
Earning Date
04-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$6.36
Revenue Next Year
N/A
$5.31
P/E Ratio
$446.57
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.03
$21.00
52 Week High
$55.65
$36.82

Technical Indicators

Market Signals
Indicator
NNNN
ENOV
Relative Strength Index (RSI) 49.55 61.47
Support Level $26.31 $26.29
Resistance Level $30.21 $26.72
Average True Range (ATR) 2.10 1.50
MACD -0.28 0.28
Stochastic Oscillator 20.78 77.57

Price Performance

Historical Comparison
NNNN
ENOV

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

About ENOV Enovis Corporation

Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.

Share on Social Networks: